| 000 | 01025cam a22002534a 4500 | ||
|---|---|---|---|
| 999 |
_c743 _d743 |
||
| 001 | 2103 | ||
| 005 | 20200708122658.0 | ||
| 008 | 040116s2004 ne af b 001 0 eng | ||
| 020 | _a0126437327 (alk. paper) | ||
| 040 | _cDLC | ||
| 082 | 0 | 0 |
_a615.19 _222 _bS5875 |
| 100 | 1 | _aSilverman, Richard B. | |
| 245 | 1 | 4 |
_aThe organic chemistry of drug design and drug action / _cRichard B. Silverman. |
| 250 | _a2nd ed. | ||
| 260 |
_aAmsterdam : _aBoston : _bElsevier Academic Press, _c2004 |
||
| 300 |
_axix, 617 p. _bill. (some col.) ; _c27 cm. |
||
| 500 | _aIncludes bibliographical references and index. | ||
| 650 | 0 | _aPharmaceutical chemistry. | |
| 650 | 0 | _aBioorganic chemistry. | |
| 650 | 0 | _aMolecular pharmacology. | |
| 650 | 0 |
_aDrugs _xDesign. |
|
| 942 | _cBK | ||
| 505 | 0 | _a1 . Introduction 2 . Drug discovery, design, and development 3 . Receptors 4 . Enzymes (catalytic receptors) 5 . Enzyme inhibition and inactivation 6 . Dna-interactive agents 7 . Drug metabolism 8 . Prodrugs and drug delivery systems | |